Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here is one stock where Wall Street’s pessimism is creating a buying opportunity and two where the skepticism is well-placed.
Two Stocks to Sell:
Helios (HLIO)
Consensus Price Target: $87.83 (6.6% implied return)
Founded on the principle of treating others as one wants to be treated, Helios (NYSE: HLIO) designs, manufactures, and sells motion and electronic control components for various sectors.
Why Do We Steer Clear of HLIO?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Efficiency has decreased over the last five years as its operating margin fell by 8.4 percentage points
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Helios is trading at $82.39 per share, or 27.6x forward P/E. Dive into our free research report to see why there are better opportunities than HLIO.
Bausch + Lomb (BLCO)
Consensus Price Target: $17.88 (4.2% implied return)
With a nearly 170-year history dedicated to vision care and eye health innovation, Bausch + Lomb (NYSE: BLCO) develops and manufactures a comprehensive range of eye health products including contact lenses, pharmaceuticals, surgical devices, and consumer eye care solutions.
Why Is BLCO Not Exciting?
- Falling earnings per share over the last three years has some investors worried as stock prices ultimately follow EPS over the long term
- 13.2 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
- Low returns on capital reflect management’s struggle to allocate funds effectively
At $17.16 per share, Bausch + Lomb trades at 19.4x forward P/E. Check out our free in-depth research report to learn more about why BLCO doesn’t pass our bar.
One Stock to Watch:
Stock Yards Bank (SYBT)
Consensus Price Target: $77.20 (-1.9% implied return)
Founded in 1904 in Louisville and named after the city's historic livestock market district, Stock Yards Bancorp (NASDAQ: SYBT) operates a regional bank providing commercial banking, wealth management, and trust services across Kentucky, Indiana, and Ohio.
Why Could SYBT Be a Winner?
- Impressive 16.9% annual net interest income growth over the last five years indicates it’s winning market share this cycle
- Notable projected net interest income growth of 16.3% for the next 12 months hints at market share gains
- Annual tangible book value per share growth of 10.1% over the last five years was superb and indicates its capital strength increased during this cycle
Stock Yards Bank’s stock price of $78.72 implies a valuation ratio of 1.9x forward P/B. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
